| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | United States | 3 | |
| #4 | Australia | 2 | |
| #5 | Canada | 2 | |
| #6 | China | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Ishii Yasuyuki | 17 |
| #2 | Morita Haruhiko | 13 |
| #3 | Akimoto Hidetoshi | 10 |
| #4 | Kawaguchi Emi | 8 |
| #5 | Hirai Toshihito | 7 |
| #6 | Tanabe Kazunari | 7 |
| #7 | Omoto Kazuya | 7 |
| #8 | Duramad Omar | 6 |
| #9 | Matsuoka Kenichi | 1 |
| #10 | Nakamura Makoto | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2019107431A1 | Haploidentical transplantation enhancer | |
| US2019000760A1 | Nanoparticle-aqueous dispersion liquid of glycosphingolipid | |
| US2015283235A1 | Immune-tolerance inducer | |
| AU2013306767A1 | Preparation for preventing or treating type I diabetes |